Board-certified medical oncologist Katherine Exten, MD, joins the physician team.

COLUMBUS, OH., November 19, 2024 — Community oncology practice Zangmeister Cancer Center, a partner practice of American Oncology Network (AON) (OTCQX: AONC), is pleased to welcome Board-certified medical oncologist Katherine Exten, MD, to its physician care team. Dr. Exten is now accepting patients at the Columbus clinic.

Dr. Exten is Board-certified in hematology, medical oncology, and internal medicine. She earned her medical degree from the Ohio State University College of Medicine, completed her internship and residency in internal medicine at the Ohio State University Wexner Medical Center, and completed a fellowship in hematology and oncology at the University of Illinois at Chicago.

“I am excited to join the physician team at Zangmeister Cancer Center,” said Dr. Exten. “Zangmeister is known for providing innovative and exceptional patient-centered care – the kind that I pride myself on delivering – and I can’t wait to collaborate with the like-minded team.”

The Zangmeister team now includes 12 medical oncologists, two gynecologic oncologists, and eight advanced practice providers across three Ohio locations. The practice is committed to providing the community with innovative cancer care that is delivered holistically based on research and evidence-based medicine. Zangmeister cancer patients have access to a diverse range of services for diagnosis, treatment, clinical trials, survivorship, and patient support that are close to home, eliminating the need to travel long distances to receive care.

“We are excited to welcome Dr. Exten to Zangmeister Cancer Center,” said Zangmeister medical oncologist Dr. Jeanna Knoble. “She is extraordinarily knowledgeable and committed to delivering top-notch patient-first care, which will further enhance our ability to offer an exceptional patient experience here in Central Ohio. We are thrilled to have her join our Zangmeister team.”

“On behalf of AON, I am pleased to welcome Dr. Exten to Zangmeister Cancer Center, and the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Dr. Exten’s background is impressive, and I am confident that our patients – and our team – will benefit immensely from her expertise and commitment to providing quality, patient-centered care in a community-based setting.”

For more information about AON, visit AONcology.com. For more information about Zangmeister Cancer Center visit zangcenter.com.

###

About American Oncology Network
American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Zangmeister Cancer Center

Designed for easy access and patient comfort, the Zangmeister Cancer Center offers a holistic array of cancer care services, including diagnostic imaging and chemotherapy treatment, laboratory services, genetic consultation, a specialty pharmacy, social support services, and access to cancer clinical trials. Zangmeister’s highly skilled and compassionate physicians use the latest advancements in the diagnosis, treatment, and prevention of cancer and blood disorders. Learn more at zangcenter.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Local oncology practice moves to a new location to continue providing enhanced cancer care to the Hot Springs Village community.

HOT SPRINGS VILLAGE, AR, Nov. 6, 2024 – Genesis Cancer and Blood Institute, a partner practice of American Oncology Network (AON) (OTCQX: AONC), has relocated its clinic in Hot Springs Village to 4419 North Highway 7, Suite 100. Current or prospective patients can call (501) 623-2731 for inquiries or to schedule an appointment.

Board-certified medical oncologist and hematologist, Lingyi Chen, MD is the primary physician at Genesis Cancer and Blood Institute’s Hot Springs Village clinic, and she is joined by the practice’s experienced clinical team. The expanded clinic includes additional private exam rooms that provide dedicated space for patient-physician conversations, and an onsite pharmacy.

“Our Hot Springs Village practice location has moved, but our standards of patient care have not changed,” said Dr. Chen. “We hold ourselves to a high standard of continuously providing exceptional, compassionate care that is central to our patient-first mindset, and is the standard in all of Genesis Cancer and Blood Institute’s 11 clinic locations. We appreciate our patients’ continued trust and look forward to serving them at our new address in Hot Springs Village.”

Genesis Cancer and Blood Institute has been delivering care to patients living in Hot Springs Village, Hot Springs, Arkadelphia, Benton, Camden, Little Rock, Mena, Nashville, Russellville, and surrounding areas for many years. The practice ensures patients receive personalized care and treatment plans that are designed exclusively for their unique needs. As a community-based practice, Genesis Cancer and Blood Institute provides affordable care in a comfortable environment while offering high-quality, state-of-the-art treatment in convenient locations.

The practice is a partner of American Oncology Network, one of the nation’s fastest-growing community-based oncology networks. Through this partnership, Genesis Cancer and Blood Institute makes additional patient care and services available such as access to the in-house specialty pharmacy with home delivery of certain medications among other benefits.

“We are excited to welcome our patients to the new space, where we will continue to prioritize their health and well-being,” said Dr. Chen. “The relocation will allow us to expand patient services and therapeutics, while also providing a larger space for additional staff to deliver one-on-one care.”

For more information about AON, visit AONcology.com. For more information about Genesis Cancer and Blood Institute, visit genesiscancerblood.com.

###

About American Oncology Network
American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Genesis Cancer and Blood Institute
Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, Dr. Jim Chen, and Dr. Brad Baltz. Learn more at genesiscancerblood.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network and Vantage Health Technologies Partner to Improve Cancer Patient Outcomes with AI-enabled Value-Based Care Platform

FORT MYERS, FL., October 29, 2024 — American Oncology Network (AON) (OTCQX: AONC), one of the fastest-growing oncology networks in the United States, has partnered with Vantage Health Technologies to enhance access to and delivery of exceptional cancer care. Vantage’s AI-enabled platform provides real-time health data for actionable insights and next-best-actions that can promote better patient experiences and outcomes, reduce provider burnout, and lower the cost of care. The platform also helps AON further enhance its Value-Based Care model in community oncology.

“We are pleased to collaborate with Vantage Health Technologies to further enhance our ability to provide exceptional, patient-first care in our community-based cancer clinics across the country,” said Alti Rahman, chief strategy and innovation officer of American Oncology Network. “Everyone benefits from Value-Based Care models powered by actionable data that offer providers a more holistic, real-time picture of their patients so they can meet them where they are and help them make better-informed decisions. Providers have the information they need to offer exceedingly personalized and effective care, patient experiences and outcomes are expected to improve, and the cost of care can be reduced for the entire ecosystem. This partnership will further our ability to provide an exceptionally high-quality experience for all.”

The first phase of the partnership will harness Vantage’s SocialHealth360 solution to enhance patient navigation and care coordination services, with an emphasis on addressing Social Determinants of Health (SDoH) for vulnerable patients. The World Health Organization cites research indicating that SDoH, such as housing, food security, transportation, and health literacy, significantly influence up to more than half of patient outcomes. Initial findings attributed to the use of SocialHealth360 found that it helped improve patient experience, treatment outcomes, and total cost of care among cancer patients. Additionally, health professionals using Vantage’s SocialHealth360 are expected to save up to five to eight hours per week on administrative tasks through workflow efficiencies, which decreases burnout and increases time they can spend helping patients. Subsequent phases of the partnership will focus on applying AI solutions to operationalize upstream and downstream Value-Based Care use-cases.

Vantage Health Technologies is part of BroadReach Group, a global healthcare social enterprise. “Healthcare globally faces shortages of providers, shrinking budgets and inadequate resources,” said Dr. John Sargent, co-founder of BroadReach Group. “We believe that technology can be a game changer for these healthcare challenges by automating and streamlining time-consuming processes, by assisting providers to manage patients more efficiently, and by empowering patients to more effectively self-manage aspects of their care. We have been proving this for the past decade in multiple countries across three continents. Our partnership with AON allows us to deploy this experience and expertise to community oncology to ensure better patient outcomes and experience, to reduce staff burnout and create pioneering approaches to value-based care.”

###

About Vantage Health Technologies
Vantage Health Technologies, part of BroadReach Group, sees a world where access to good health enables people to flourish. BroadReach Group helps health organizations deliver better outcomes, improved resource efficiency, cost savings, enhanced organizational performance, and sustainable systems.

Vantage delivers innovative artificial intelligence (AI)-enabled solutions for healthcare organizations to get the most impact out of their resources and to transform how work gets done. Its solutions go beyond dashboards, empowering health professionals to make the best decisions and take the next-best-actions at the best time. Vantage believes that data alone cannot solve the world’s most complex health challenges; it also requires a deep understanding of the social, cultural, and economic context in which people live.

For more information, please visit Vantage Health Technologies or follow us on LinkedIn:

BroadReach Group; Vantage Health Technologies

About American Oncology Network
American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Vantage Health Technologies / BroadReach Media Contact
Shelley Diesel
Vantage Health Technologies
Shelley.Diesel@brhc.com
+27-215-148-300

American Oncology Network Media Contact
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com
+1-541-221-1472

Local oncology practice expands its clinic moving to a larger suite in the same building to continue providing enhanced cancer care to the Conroe community.

CONROE, TX., Oct. 14, 2024 – Woodlands Cancer Institute, a partner practice of American Oncology Network (AON) (OTCQX: AONC), has expanded its clinic in Conroe and moved to a new, larger suite in the same building at 603 Conroe Medical Drive. The expanded clinic is now located at Suite 160. It is now open to new and current patients.

Board-certified medical oncologists, Eric P. Kleinbaum, MD, Sandeep “Kodi” Kodityal, MD, FACP, and Krishna K. Pachipala, MD, MRCP are the physicians at the newly expanded Woodlands Cancer Institute suite in Conroe, while Board-certified radiation oncologist Jason Berilgen, MD continues to see new and existing patients in the same building at 603 Conroe Medical Drive, in Suites 100 and 110. The newly expanded clinic in Suite 160 offers four private exam rooms that provide dedicated space for patient-physician conversations and 12 infusion chairs for patients receiving certain therapies as part of their treatment plans. The new suite is also equipped with an onsite laboratory for immediate blood draws and other necessary procedures.

“Our clinic has expanded to a new suite in the same conveniently located building to provide additional services to our patients,” said Dr. Kleinbaum. “We hold ourselves to a high standard of continuously providing exceptional care and services to our patients in a compassionate and holistic manner that is central to our patient-first mindset. This is the standard in all three Woodlands Cancer Institute clinic locations. We appreciate our patients’ continued trust and look forward to serving them at our newly expanded clinic in Conroe.”

Woodlands Cancer Institute has been delivering care to patients living in Conroe and the surrounding area for many years. The practice ensures patients receive personalized care and treatment plans that are designed exclusively for their unique needs. As a community-based practice, Woodlands Cancer Institute provides affordable care in a comfortable environment while offering high-quality, state-of-the-art treatment in convenient locations.

The practice is a partner of American Oncology Network, one of the nation’s fastest-growing community-based oncology networks. Through this partnership, Woodlands Cancer Institute makes additional patient care and services available such as access to the in-house specialty pharmacy with home delivery of certain medications among other benefits.

“We cannot wait to welcome our patients to the new space, where we will continue to prioritize their health and well-being,” said Dr. Kleinbaum. “The new suite will allow us to expand patient services and therapeutics, while also providing a larger space for additional staff to deliver one-on-one care.”

For more information about AON, visit AONcology.com. For more information about Woodlands Cancer Institute, visit woodlandscancer.com.

###

About American Oncology Network
American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Woodlands Cancer Institute
Woodlands Cancer Institute is a community-based medical oncology, radiation oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, we strive to provide the best possible experience to patients and their families throughout the healthcare journey. Learn more at woodlandscancer.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Board-certified medical oncologist Brad Baltz, MD, joins the physician team.

LITTLE ROCK, ARK., September 5, 2024 — Community oncology practice Genesis Cancer and Blood Institute, a partner practice of American Oncology Network (AON) (OTCQX: AONC), is pleased to welcome Board-certified medical oncologist Brad Baltz, MD, to its physician care team. He will work alongside Drs. Timothy Webb, Robert Muldoon, Stephen “Fred” Divers, Lynn Cleveland, Lingyi Chen, Sunil Kakadia, Kristen Sager, and Jim Chen.

Dr. Baltz is Board-certified in medical oncology. He earned his medical degree from the University of Arkansas College of Medicine and completed an internship, residency, and a fellowship in hematology-oncology at the University of Arkansas for Medical Sciences in Little Rock.

“I am excited to join the physician team at Genesis Cancer and Blood Institute,” said Dr. Baltz. “Genesis is known for providing innovative and exceptional patient-centered care – the kind that I pride myself on delivering, so it was an easy decision to join.”

With the addition of Dr. Baltz, Genesis Cancer and Blood Institute has opened a second clinic in Little Rock at 5620 W. Markham St., Little Rock, AR 72205. The new Little Rock clinic has six consult rooms, an onsite lab, and 17 infusion chairs. Both Dr. Baltz and Dr. Chen are now accepting patients there.

The Genesis team now includes nine medical oncologists and seven advanced practice providers across 12 Arkansas locations, including the original Little Rock clinic where Dr. Kakadia is accepting patients at 1300 Centerview Dr., Little Rock, AR 72211. The practice is committed to providing the community with innovative cancer care that is delivered holistically based on research and evidence-based medicine. Genesis cancer patients have access to a diverse range of services for diagnosis, treatment, clinical trials, survivorship, and patient support that are close to home, eliminating the need to travel long distances to receive care.

“We are pleased to welcome Dr. Baltz to Genesis Cancer and Blood Institute,” said Genesis medical oncologist Dr. Timothy Webb. “He is extraordinarily knowledgeable and committed to delivering top-notch patient-first care, which will further enhance our reputation for delivering an exceptional patient experience. We are looking forward to collaborating with him.”

“On behalf of AON, I am thrilled to welcome Dr. Baltz to Genesis Cancer and Blood Institute and the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Dr. Baltz has an impressive background, and I am confident that our patients – and our team – will benefit immensely from his expertise and commitment to providing quality, patient-centered care in a community-based setting.”

Dr. Baltz began accepting new patients at the Midtown Little Rock clinic on September 1, 2024.

For more information about AON, visit AONcology.com. For more information about Genesis Cancer and Blood Institute, visit genesiscancerblood.com.

###

About American Oncology Network
American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Genesis Cancer and Blood Institute
Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, Dr. Jim Chen, and Dr. Brad Baltz. Learn more at genesiscancerblood.com.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com